238 related articles for article (PubMed ID: 14742550)
1. Systemic Th1 immunization of mice against Helicobacter pylori infection with CpG oligodeoxynucleotides as adjuvants does not protect from infection but enhances gastritis.
Sommer F; Wilken H; Faller G; Lohoff M
Infect Immun; 2004 Feb; 72(2):1029-35. PubMed ID: 14742550
[TBL] [Abstract][Full Text] [Related]
2. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization.
Akhiani AA; Stensson A; Schön K; Lycke N
Scand J Immunol; 2006 Feb; 63(2):97-105. PubMed ID: 16476008
[TBL] [Abstract][Full Text] [Related]
3. Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells.
Akhiani AA; Pappo J; Kabok Z; Schön K; Gao W; Franzén LE; Lycke N
J Immunol; 2002 Dec; 169(12):6977-84. PubMed ID: 12471132
[TBL] [Abstract][Full Text] [Related]
4. Systemic immunization with urease protects mice against Helicobacter pylori infection.
Guy B; Hessler C; Fourage S; Haensler J; Vialon-Lafay E; Rokbi B; Millet MJ
Vaccine; 1998 May; 16(8):850-6. PubMed ID: 9627943
[TBL] [Abstract][Full Text] [Related]
5. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection.
Shi T; Liu WZ; Gao F; Shi GY; Xiao SD
Helicobacter; 2005 Feb; 10(1):71-9. PubMed ID: 15691317
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis.
Raghavan S; Svennerholm AM; Holmgren J
Infect Immun; 2002 Aug; 70(8):4621-7. PubMed ID: 12117975
[TBL] [Abstract][Full Text] [Related]
7. Immunization with a recombinant fusion protein protects mice against Helicobacter pylori infection.
Ghasemi A; Mohammad N; Mautner J; Taghipour Karsabet M; Amani J; Ardjmand A; Vakili Z
Vaccine; 2018 Aug; 36(34):5124-5132. PubMed ID: 30041879
[TBL] [Abstract][Full Text] [Related]
8. Intranasal immunization with an epitope-based vaccine results in earlier protection, but not better protective efficacy, against Helicobacter pylori compared to subcutaneous immunization.
Li H; Zhang J; He Y; Li B; Chen L; Huang W; Zou Q; Wu C
Immunol Res; 2015 Jul; 62(3):368-76. PubMed ID: 26044541
[TBL] [Abstract][Full Text] [Related]
9. Effects of a Th1- versus a Th2-biased immune response in protection against Helicobacter pylori challenge in mice.
Taylor JM; Ziman ME; Canfield DR; Vajdy M; Solnick JV
Microb Pathog; 2008 Jan; 44(1):20-7. PubMed ID: 17683897
[TBL] [Abstract][Full Text] [Related]
10. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice.
Nyström J; Raghavan S; Svennerholm AM
Microbes Infect; 2006 Feb; 8(2):442-9. PubMed ID: 16243563
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.
Inoue K; Shiota S; Yamada K; Gotoh K; Suganuma M; Fujioka T; Ahmed K; Iha H; Nishizono A
Helicobacter; 2009 Oct; 14(5):135-43. PubMed ID: 19751439
[TBL] [Abstract][Full Text] [Related]
12. Systemic immunization with an epitope-based vaccine elicits a Th1-biased response and provides protection against Helicobacter pylori in mice.
Li HB; Zhang JY; He YF; Chen L; Li B; Liu KY; Yang WC; Zhao Z; Zou QM; Wu C
Vaccine; 2012 Dec; 31(1):120-6. PubMed ID: 23137845
[TBL] [Abstract][Full Text] [Related]
13. Protection against experimental Helicobacter pylori infection after immunization with inactivated H. pylori whole-cell vaccines.
Raghavan S; Hjulström M; Holmgren J; Svennerholm AM
Infect Immun; 2002 Nov; 70(11):6383-8. PubMed ID: 12379718
[TBL] [Abstract][Full Text] [Related]
14. Immunization with recombinant FliD confers protection against Helicobacter pylori infection in mice.
Ghasemi A; Mohammad N; Mautner J; Karsabet MT; Ardjmand A; Moniri R
Mol Immunol; 2018 Feb; 94():176-182. PubMed ID: 29324238
[TBL] [Abstract][Full Text] [Related]
15. IgA antibodies impair resistance against Helicobacter pylori infection: studies on immune evasion in IL-10-deficient mice.
Akhiani AA; Stensson A; Schön K; Lycke NY
J Immunol; 2005 Jun; 174(12):8144-53. PubMed ID: 15944323
[TBL] [Abstract][Full Text] [Related]
16. Immunization with attenuated Salmonella typhimurium producing catalase in protection against gastric Helicobacter pylori infection in mice.
Chen M; Chen J; Liao W; Zhu S; Yu J; Leung WK; Hu P; Sung JJ
Helicobacter; 2003 Dec; 8(6):613-25. PubMed ID: 14632677
[TBL] [Abstract][Full Text] [Related]
17. Intranasal immunization with immunodominant epitope peptides derived from HpaA conjugated with CpG adjuvant protected mice against Helicobacter pylori infection.
Yang WC; Sun HW; Sun HQ; Yuan HM; Li B; Li HB; Hu J; Yang Y; Zou QM; Guo H; Wu C; Chen L
Vaccine; 2018 Oct; 36(42):6301-6306. PubMed ID: 30217524
[TBL] [Abstract][Full Text] [Related]
18. A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection.
Sjökvist Ottsjö L; Flach CF; Clements J; Holmgren J; Raghavan S
Infect Immun; 2013 May; 81(5):1532-40. PubMed ID: 23439305
[TBL] [Abstract][Full Text] [Related]
19. [The role of local immune response in gastric mucosa in the protection induced by Helicobacter pylori vaccine with chitosan as adjuvant].
Xie Y; Gong YF; Zhou NJ; Chen J; Zhou XJ; Lü NH; Wang CW
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2629-35. PubMed ID: 16321324
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice.
Taylor JM; Ziman ME; Huff JL; Moroski NM; Vajdy M; Solnick JV
Vaccine; 2006 Jun; 24(23):4987-94. PubMed ID: 16621176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
